Autonomic Dysfunction in Parkinson’s Disease Link with disease severity and other non-motor signs
Objective: Clarify the relationship between autonomic dysfunction, disease severity and NMS in PD patients. Background: Parkinson’s disease (PD) is characterized by a combination of motor…Validation of the International Parkinson and Movement Disorder Society – Non-Motor Symptoms – Questionnaire (MDS-NMS-Q)
Objective: To validate the self-completed version of the International Movement Disorder Society – Non-Motor Rating Scale (MDS-NMS)1, named the MDS-NMS – Questionnaire (MDS-NMS-Q). Background: The…Exploring Supervised and Real-World Mobility in People with Parkinson’s Disease with and without Nocturnal Hypokinesia
Objective: To evaluate supervised and real-world mobility in people with Parkinson’s disease (PwPD) with and without nocturnal hypokinesia (NH). Background: Mobility impairment and NH are…Beyond constipation: gastrointestinal phenomena in Parkinson’s disease
Objective: To describe the prevalence of gastrointestinal manifestations in patients with Parkinson's disease in a Brazilian movement disorders outpatient clinic and evaluate their associated factors…Misinterpretation of Hypnagogic/hypnopompic Experiences as Hallucinations in Parkinson’s Disease
Objective: To investigate whether hypnagogic/hypnopompic experiences are clinically misinterpreted as hallucinations in Parkinson’s disease. Background: In Lewy body disorders, the progression of the disease can…Comorbidity of schizophrenia and Parkinson’s disease: a clinical case report
Objective: To describe the case of a patient with paranoid schizophrenia followed by the onset of the Parkinson’s disease at the 44-year age Background: Currently…Diagnostic Challenges in Functional Neurological Disorder: Convergent Psychogenic Non-Epileptic Seizures and Psychosis
Objective: To dissect the diagnostic challenges in distinguishing Functional Neurological Disorder (FND) coexisting with psychosis, highlighting the imperative for comprehensive and nuanced neuro-psychiatric assessment. Background:…Ibudilast, a Phosphodiesterase Inhibitor, Alleviates Huntington’s Disease Pathology through Neuroinflammation Modulation and Signaling Pathway Regulation in a Rat Model
Objective: This research aims to assess whether Ibudilast (IBD), a phosphodiesterase IV (PDE IV) inhibitor, can mitigate the damage induced by 3-nitropropionic acid (3-NP) in…Rare Clinical Manifestation of Tardive Dyskinesia In Schizophrenic Patient on Quetiapine and Sertraline: A Case Report
Objective: To underscore the rarity of tardive dyskinesia manifestation in a schizophrenic patient, prescribed second-generation DRBA agents, quetiapine and SSRI sertraline. Background: Tardive dyskinesia is…PD in Tanzania: representative in city dwellers, absent in nomadic tribespeople?
Objective: To investigate the aetiology of PD demographically in an under researched region. Background: PD monogenic and susceptibility risk factors explain little to none of…
- « Previous Page
- 1
- …
- 125
- 126
- 127
- 128
- 129
- …
- 181
- Next Page »